Variation in the use of bevacizumab and ranibizumab for branch retinal vein occlusionTo describe frequency and variation of intravitreal bevacizumab and ranibizumab use for branch retinal vein occlusion (BVO) in the United States (US) with the aim of improving cost effective ophthalmic treatment utilization.Yu, FeiCreatorWu, Annie M.CreatorWu, Connie M.CreatorGreenberg, Paul B.CreatorLum, FloraCreatorColeman, Anne LCreator2017bevacizumabranibizumabbranch retinal vein occlusionstill imageresearch poster10.26300/dmpp-2e19